Manfred Horst

Manfred Horst, MD, PhD, MBA, studied medicine in Munich, Montpellier and London. He spent most of his career in the pharmaceutical industry, most recently in the research & development department of Merck & Co/MSD. Since 2017, he had been working as an independent consultant for pharma, biotech and healthcare companies (www.manfred-horst-consulting.com).

Another Look at Covid Vaccine Studies

All the observational studies which have been carried out with the Covid-19 vaccines suffer, apart from some of the well-known general biases, from exactly the same fundamental flaw:  They show a decrease in “Covid-19-related” symptom-free or symptomatic cases, hospitalizations or deaths, but they do not ask the question whether this decline in test-positive patients translates into an overall reduction of flu cases, of (atypical) pneumonias, of hospitalizations and deaths. 

Mortality Data

A Closer look at US 2020 Mortality Data

The increase in age-specific death rates in the younger parts of the population (15 – 54 years old) has been extraordinarily significant – it is above 20%. And one cannot even state the hypothesis (which – even if the numbers fit – would still have to be examined) that this increase is due to COVID-19: Just look at the numbers, the COVID-19 death rates in these age groups are far too small. Something else must have led to this increase in mortality in the younger population. 

A Closer Look at Germany’s Covid Mortality

The conclusion is that the Coronavirus has no influence on the mortality of the 50-70 age groups. And that very conclusion is the same for all groups below 80 years of age. As 80 is the average age of death in the population, the general conclusion therefore is that the Coronavirus has no influence on population mortality.

Stay Informed with Brownstone